Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
Despite the known risk of diabetes-induced cardiac fibrosis, less is known about whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Peroxisome proliferator-activated ...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Wei-Ting Chang, Juei-Tang Cheng and Zhih-Cherng Chen Source Type: research